What does CUSIP 75886F107 represent in this 13F holders report?

CUSIP 75886F107 is the security identifier for REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in Q2 2021?

959 institutional investors reported REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)

CUSIP: 75886F107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 104,986,330
Total 13F shares: 88,855,592
Share change: -698,829
Total reported value: $49,577,081,270
Put/Call ratio: 127%
Price per share: $558.54
Number of holders: 959
Value change: -$361,559,165
Number of buys: 501
Number of sells: 385

Quarterly Holders Quick Answers

What is CUSIP 75886F107?
CUSIP 75886F107 identifies REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 75886F107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	10%	10,935,989	$5,174,253,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	9.2%	9,649,547	$4,565,587,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	7.6%	8,000,412	$3,785,316,000	—	31 Mar 2021	13F
Capital World Investors	13F	Company	5.9%	6,184,120	$2,925,946,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	4.3%	4,547,301	$2,151,510,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.7%	3,876,380	$1,834,070,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	2.9%	3,035,655	$1,436,290,000	—	31 Mar 2021	13F
LOOMIS SAYLES & CO L P	13F	Company	2.7%	2,876,368	$1,360,925,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	2%	2,077,251	$982,831,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.5%	1,610,190	$759,590,000	—	31 Mar 2021	13F
Capital International Investors	13F	Company	1.2%	1,290,161	$610,427,000	—	31 Mar 2021	13F
ARK Investment Management LLC	13F	Company	1.2%	1,218,970	$576,743,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.1%	1,179,811	$558,216,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	1.1%	1,177,092	$556,930,000	—	31 Mar 2021	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	1.1%	1,104,761	$522,706,000	—	31 Mar 2021	13F
HARRIS ASSOCIATES L P	13F	Company	0.98%	1,033,578	$489,027,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.93%	980,408	$463,870,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.82%	862,743	$408,198,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.81%	846,037	$400,295,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.75%	792,236	$374,839,000	—	31 Mar 2021	13F
Sustainable Growth Advisers, LP	13F	Company	0.75%	791,888	$374,674,000	—	31 Mar 2021	13F
Neuberger Berman Group LLC	13F	Company	0.72%	755,789	$357,414,000	—	31 Mar 2021	13F
Legal & General Group Plc	13F	Company	0.67%	708,644	$335,288,000	—	31 Mar 2021	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.62%	655,652	$310,215,000	—	31 Mar 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.59%	618,346	$292,564,226	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.58%	606,822	$287,112,000	—	31 Mar 2021	13F
FRANKLIN RESOURCES INC	13F	Company	0.56%	590,004	$279,154,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.56%	588,377	$278,385,000	—	31 Mar 2021	13F
CREDIT SUISSE AG/	13F	Company	0.55%	573,453	$271,325,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.48%	499,790	$236,471,000	—	31 Mar 2021	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.47%	495,855	$234,609,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.46%	480,248	$227,224,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	0.45%	469,344	$222,066,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.44%	464,262	$219,660,000	—	31 Mar 2021	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.41%	432,760	$204,756,000	—	31 Mar 2021	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.41%	425,374	$201,262,000	—	31 Mar 2021	13F
S.c.a. Candriam	13F	Individual	0.38%	403,641	$187,313,000	—	31 Mar 2021	13F
FIL Ltd	13F	Company	0.37%	386,103	$182,680,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.35%	362,728	$171,621,000	—	31 Mar 2021	13F
APG Asset Management N.V.	13F	Company	0.4%	424,901	$171,052,000	—	31 Mar 2021	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.28%	290,661	$137,523,000	—	31 Mar 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.27%	284,566	$134,872,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.26%	268,463	$127,020,000	—	31 Mar 2021	13F
HSBC HOLDINGS PLC	13F	Company	0.25%	266,406	$125,833,000	—	31 Mar 2021	13F
LSV ASSET MANAGEMENT	13F	Company	0.24%	251,951	$119,208,000	—	31 Mar 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.24%	250,147	$118,353,000	—	31 Mar 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.23%	240,256	$113,675,000	—	31 Mar 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.22%	234,327	$110,873,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.2%	214,152	$101,323,000	—	31 Mar 2021	13F
Assenagon Asset Management S.A.	13F	Company	0.18%	191,681	$90,692,000	—	31 Mar 2021	13F

Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q2 2021

As of 30 Jun 2021, REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by 959 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 88,855,592 shares. The largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, LOOMIS SAYLES & CO L P, GEODE CAPITAL MANAGEMENT, LLC, and HARRIS ASSOCIATES L P. This page lists 961 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

906

Q2 2021 holders

959

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.